» Articles » PMID: 32013265

MiR-20b and MiR-451a Are Involved in Gastric Carcinogenesis Through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model

Abstract

Gastric cancer (GC) is one of the most common and lethal gastrointestinal malignancies worldwide. Many studies have shown that development of GC and other malignancies is mainly driven by alterations of cellular signaling pathways. MicroRNAs (miRNAs) are small noncoding molecules that function as tumor-suppressors or oncogenes, playing an essential role in a variety of fundamental biological processes. In order to understand the functional relevance of miRNA dysregulation, studies analyzing their target genes are of major importance. Here, we chose to analyze two miRNAs, miR-20b and miR-451a, shown to be deregulated in many different malignancies, including GC. Deregulated expression of miR-20b and miR-451a was determined in GC cell lines and the INS-GAS mouse model. Using Western Blot and luciferase reporter assay we determined that miR-20b directly regulates expression of and and miR-451a: and . Loss-of-function experiments revealed that down-regulation of miR-20b and up-regulation of miR-451a expression exhibits an anti-tumor effect in vitro (miR-20b: reduced viability, colony formation, increased apoptosis rate, and miR-451a: reduced colony forming ability). To summarize, the present study identified that expression of miR-20b and miR-451a are deregulated in vitro and in vivo and have a tumor suppressive role in GC through regulation of the PI3K/AKT/mTOR signaling pathway.

Citing Articles

The miR-451a facilitates natural killer cell-associated immune deficiency after ischemic stroke.

Li Y, Guan X, Lan T, Zhang Z, Zhang Y, Jiang S J Cereb Blood Flow Metab. 2025; :271678X251321641.

PMID: 39985210 PMC: 11846095. DOI: 10.1177/0271678X251321641.


The efficacy of plasma exosomal miRNAs as predictive biomarkers for PD-1 blockade plus chemotherapy in gastric cancer.

Hua Y, Luo S, Li Q, Song G, Tian X, Wang P Transl Cancer Res. 2024; 13(11):6336-6346.

PMID: 39697742 PMC: 11651786. DOI: 10.21037/tcr-24-2151.


Bacillamide D produced by Bacillus cereus from the mouse intestinal bacterial collection (miBC) is a potent cytotoxin in vitro.

Hohmann M, Brunner V, Johannes W, Schum D, Carroll L, Liu T Commun Biol. 2024; 7(1):655.

PMID: 38806706 PMC: 11133360. DOI: 10.1038/s42003-024-06208-3.


Non-Coding RNA as Biomarkers and Their Role in the Pathogenesis of Gastric Cancer-A Narrative Review.

Bakinowska E, Kielbowski K, Skorka P, Dach A, Olejnik-Wojciechowska J, Szwedkowicz A Int J Mol Sci. 2024; 25(10).

PMID: 38791187 PMC: 11121563. DOI: 10.3390/ijms25105144.


Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis.

Loe A, Zhu L, Kim T Exp Mol Med. 2023; 55(1):22-31.

PMID: 36653445 PMC: 9898530. DOI: 10.1038/s12276-023-00926-0.


References
1.
Minna E, Romeo P, Dugo M, De Cecco L, Todoerti K, Pilotti S . miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma. Oncotarget. 2016; 7(11):12731-47. PMC: 4914318. DOI: 10.18632/oncotarget.7262. View

2.
Al-Batran S, Ducreux M, Ohtsu A . mTOR as a therapeutic target in patients with gastric cancer. Int J Cancer. 2011; 130(3):491-6. DOI: 10.1002/ijc.26396. View

3.
Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D . Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009; 24(4):652-7. DOI: 10.1111/j.1440-1746.2008.05666.x. View

4.
Young L, Sung J, Stacey G, Masters J . Detection of Mycoplasma in cell cultures. Nat Protoc. 2010; 5(5):929-34. DOI: 10.1038/nprot.2010.43. View

5.
Farazi T, Hoell J, Morozov P, Tuschl T . MicroRNAs in human cancer. Adv Exp Med Biol. 2013; 774:1-20. PMC: 3704221. DOI: 10.1007/978-94-007-5590-1_1. View